ACCREDO HEALTH
DEAD

Serial Number

77353871

Owner

ACCREDO HEALTH GROUP, INC.

Attorney

Grady M. Garrison

Filing Date

Dec 17, 2007

Add to watchlist:

No watchlists yet
View on USPTO

ACCREDO HEALTH Trademark

Serial Number: 77353871

ACCREDO HEALTH is a trademark filed by ACCREDO HEALTH GROUP, INC. on December 17, 2007. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ACCREDO HEALTH GROUP, INC. (23 trademarks)

1640 CENTURY CENTER PARKWAY
MEMPHIS, TN 38134

Entity Type: 03

Trademark Details

Filing Date

December 17, 2007

Registration Date

Not Registered

Published for Opposition

August 26, 2008

Goods & Services

Providing patient educational services, namely, conducting programs in the field of chronic disease, proper product-reconstitution and administration, and resources appropriate for support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, namely, conducting workshops for children to help them to understand hemophilia; educational services, namely, conducting workshops for children to help them understand hemophilia

Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia; pharmaceutical preparations for the treatment of chronic diseases, namely disorders requiring intravenous immunoglobulin therapy; pharmaceutical preparations for the treatment of hemophilia

Printed publications, namely, magazines featuring articles and information on blood disorders; newsletters and pamphlets featuring a series of stories on the subject of living with hemophilia; newsletters on the subject of hemophilia and related health issues

Providing information about government benefits and entitlements, and insurance, and related social services to people with chronic diseases and other health conditions

Retail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia

Providing patient advocate services to people with chronic diseases and other health conditions regarding government benefits and entitlements, and insurance, and related social services

Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counseling, namely, offering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical services, namely, specialized pharmaceutical advice for individuals with bleeding disorders

Providing clinical research in the field of medicine for product manufacturers, pharmaceutical and biotech companies, contract research organizations and insurance providers, and providing consulting services in support of new drug product launches; medical services, namely, on-line analysis of infusion and bleeding activity for hemophiliacs

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 22, 2009 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 22, 2009 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 18, 2008 NOAM
PUBLISHED FOR OPPOSITION
Aug 26, 2008 PUBO
NOTICE OF PUBLICATION
Aug 6, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 22, 2008 PREV
ASSIGNED TO LIE
Jul 22, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2008 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2008 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2008 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2008 DOCK
NEW APPLICATION ENTERED
Dec 20, 2007 NWAP